ArticleOncotarget2017

Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells.

Won-Jun Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.